Moderna Inc

NASDAQ:MRNA   3:59:58 PM EDT
132.32
+0.02 (+0.02%)
: $129.31 -3.01 (-2.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)52.86B
Current PEN/A
Forward PE 6.29
2yr Forward PE 8.43
See more stats
Estimates Current Quarter
Revenue$2.17 Billion
Adjusted EPS$3.01
See more estimates
10-Day MA$143.27
50-Day MA$144.39
200-Day MA$95.96
See more pivots

Moderna, Inc. Stock, NASDAQ:MRNA

200 Technology Square, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.714.6500
Number of Employees: 830

Description

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.